Unlock regulatory insights with Watson. Learn More
Return to Docket

Chloropicrin; Revised Risk Assessments, Notice of Availability, and Solicitation of Risk Reduction Options (Phase 5 of 6-Process)

Abstract: For further information contact: Jose Gayoso (703) 347-8652 Mail Code (7508P)
Type: Non-Rule Making
Location HQ-OPP

Supporting Documents (36)